Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2017
SIETES contiene 92005 citas

 
 
 1 a 20 de 226 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Sondergaard KB, Weeke P, Wissenberg M, Olsen A-MS, Fosbol EL, Lippert FK, Torp-Pedersen C, Gislason GH, Folke F. Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case–time–control study. Eur Heart J 2017;3:100-7. [Ref.ID 101478]
2.Enlace a cita original
Renoux C, Dell'Aniello S, Khairy P, Marras C, Bugden S, Turin TC, Blais L, Tamim H, Evans C, Steele R, Dormuth C, Ernst P, the Canadian Network for Observational Drug Effect Studies (CNODES) investigators. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease. Br J Clin Pharmacol 2016;82:461-72. [Ref.ID 100688]
3.Tiene citas relacionadas Cita con resumen
Odutayo A, Wong CX, Hsiao A, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 2016;354:i4482. [Ref.ID 100671]
4. Cita con resumen
Anónimo. Métoclopramide, dompéridone: morts subites, arythmies ventriculaires. Prescrire 2016;36:351-4. [Ref.ID 100540]
5.Enlace a cita original Cita con resumen
Page II RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J, On behalf of the American Heart Association Clinical Pharmacology and Heart Failure and Trans- plantation Committees of the Council on Clini- cal Cardiology, Coun- cil on Cardiovascular Surgery and Anesthesia, Council on Cardio- vascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Drugs that may cause or exacerbate heart failure. A scientific statement from the American Heart Association. Circulation 2016;134:9 de agosto. [Ref.ID 100519]
6. Cita con resumen
Anónimo. Riesgo de muerte súbita con el uso concomitante de cotrimoxazol y algunos inhibidores del sistema renina-angiotensina. Butlletí de Farmacovigilància de Catalunya 2015;13:1-2. [Ref.ID 99829]
7. Cita con resumen
Degner D. Severe adverse reactions associated with quetiapine. BMJ 2015;350:h1575. [Ref.ID 98872]
8. Cita con resumen
Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN, Canadian Drug Safety and Effectiveness Research Network.. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone. Can Med Assoc J 2015;187:E138-143. [Ref.ID 98851]
9. Cita con resumen
Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN, for the Canadian Drug Safety and Effectiveness Research Network. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone. Can Med Assoc J 2015;187:E138-43. [Ref.ID 98766]
10.Tiene citas relacionadas Cita con resumen
Fralick M, Macdonald EM, Gomes T, Antoniou T, Hollands S, Mamdani MM, Juurlink DN, for the Canadian Drug Safety and Effectiveness Research Network (CDSERN). Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study. BMJ 2014;349:g6196. [Ref.ID 98361]
11.Tiene citas relacionadas
Etminan M, Brophy JM. Antibiotics and sudden death in adults taking renin-angiotensin system blockers. BMJ 2014;349:g6242. [Ref.ID 98356]
12. Cita con resumen
Weeke P, Jensen A, Folke F, Gislason GH, Fosbol EL, Wissenberg M, Lippert FK, Christensen EF, Nielsen SL, Holm E, Kanters JK, Poulsen HE, Kober L, Torp-Pedersen C. Antipsychotics and associated risk of out-of-hospital cardiac arrest. Clin Pharmacol Ther 2014;96:490-7. [Ref.ID 97924]
13. Cita con resumen
Svanström H, Pasernak B, Hviid A. Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study. BMJ 2014;349:g4930. [Ref.ID 97856]
14. Cita con resumen
Sasich LD, Abi-Jaoude E. Sharing of clinical trial data. FDA drug approval packages are already freely available. BMJ 2013;347:19. [Ref.ID 96167]
15.Tiene citas relacionadas Cita con resumen
Coxib and traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013;382:769-79. [Ref.ID 96000]
16.Tiene citas relacionadas Cita con resumen
Griffin MR. High-dose non-steroidal anti-inflammatories: painful choices. Lancet 2013;382:746-8. [Ref.ID 95994]
17. Cita con resumen
Poluzzi E, Raschi E, Koci A, Moretti U, Spina E, Behr ER, Sturkenboom M, De Ponti F. Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Saf 2013;36:467-79. [Ref.ID 95666]
18. Cita con resumen
Haugaa KH, Bos JM, Tarrell RF, Morlan BW, Caraballo PJ, Ackerman MJ. Institution-wide QT alert system identifies patients with a high risk of mortality. Mayo Clin Proc 2013;88:315-25. [Ref.ID 95349]
19. Cita con resumen
Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012;308:1024-33. [Ref.ID 93760]
20.Tiene citas relacionadas
Ray WA, Murray KT, Stein CM. Azithromycin and the risk of cardiovascular death. Author/editor response. N Engl J Med 2012;367:775. [Ref.ID 93628]
Seleccionar todas
 
 1 a 20 de 226 siguiente >>